Skip to main navigation Skip to search Skip to main content

An Open-Label, Multi-Center, Rollover Study to Provide Continued Treatment Access for Participants Enrolled in Studies of BXQ-350

Grants and Contracts Details

StatusFinished
Effective start/end date5/27/20 → 3/12/25

Funding

  • CTI Clinical Trial and Consulting Services: $105,058.00